Barbara Schmalfeldt

Professor Barbara Schmalfeldt is a distinguished researcher and clinician at the Clinic and Polyclinic for Gynecology within the Faculty of Medicine at the University Medical Center Hamburg-Eppendorf. With over two decades of research activity documented through more than 200 publications, she has established herself as a leading expert in gynecological oncology, particularly in ovarian cancer research.

Her research interests span multiple critical areas in women's cancer care, including:

• Development and evaluation of novel therapeutic approaches for ovarian cancer
• HPV-related gynecological conditions and prevention strategies
• Biomarker discovery for cancer prognosis and treatment response
• Surgical techniques and outcomes in advanced gynecological cancers
• Implementation of innovative treatment protocols in clinical practice

Analysis of her recent publications (2023-2025) reveals a strong focus on clinical trial participation, particularly in major international studies like PAOLA-1/ENGOT-ov25, as well as translational research bridging laboratory findings to clinical applications. Her work demonstrates expertise across the spectrum from basic tumor biology to large-scale clinical outcomes research, with particular emphasis on personalized treatment approaches and quality-of-life considerations for cancer patients.

Dr. Schmalfeldt actively collaborates with major European research networks including JAGO, NOGGO, and ENGOT, contributing to international guidelines and position statements such as those from FIGO. Her research has appeared in leading journals including New England Journal of Medicine, Journal of Clinical Oncology, and Annals of Oncology, reflecting the high impact of her work in the field.

Her leadership extends to protocol development for innovative interventions, as evidenced by her involvement in the BENITA study examining exercise and nutrition interventions for ovarian cancer patients during chemotherapy. She also contributes to broader discussions in women's health through research on contraceptive strategies for cancer prevention and analysis of sexual assault patterns during the pandemic.